Meeting
2017 Genitourinary Cancers Symposium
Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial.
Authors
Abdenour Nabid
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
Abdenour Nabid , Marie-Pierre Garant , Eric Vigneault , Luis Souhami , Celine Lemaire , Marc-Andre Brassard , Boris Bahoric , Robert Archambault , Francois Vincent , Thu-Van Nguyen-Huynh , Redouane Bettahar , Derek R Wilke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
NCT00223145
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 78)
DOI
10.1200/JCO.2017.35.6_suppl.78
Abstract #
78
Poster Bd #
D13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Propensity score matched analysis of major adverse cardiac events in patients with localized prostate cancer receiving short term vs long term ADT.
First Author: Ye Yuan
Poster
2015 ASCO Annual Meeting
A phase III trial of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy.
First Author: Abdenour Nabid
Poster
2024 ASCO Genitourinary Cancers Symposium
Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.
First Author: Abdenour Nabid
Poster
2018 Genitourinary Cancers Symposium
Phase II study of enzalutamide monotherapy with radiation therapy for intermediate risk prostate cancer.
First Author: Glenn Bubley